{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:33:05Z","timestamp":1788449585955,"version":"build-2803163510"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12928-025-01126-5","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T19:08:13Z","timestamp":1743880093000},"page":"465-473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pericoronary adipose tissue: potential for pathological diagnosis and therapeutic applications"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0579-6196","authenticated-orcid":false,"given":"Tomoya","family":"Hara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Sata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"key":"1126_CR1","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1111\/bph.13666","volume":"174","author":"I Akoumianakis","year":"2017","unstructured":"Akoumianakis I, Tarun A, Antoniades C. Perivascular adipose tissue as a regulator of vascular disease pathogenesis: identifying novel therapeutic targets. Br J Pharmacol. 2017;174:3411\u201324. https:\/\/doi.org\/10.1111\/bph.13666.","journal-title":"Br J Pharmacol"},{"key":"1126_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1253\/circj.CJ-20-0935","volume":"85","author":"K Tanaka","year":"2020","unstructured":"Tanaka K, Fukuda D, Sata M. Roles of epicardial adipose tissue in the pathogenesis of coronary atherosclerosis\u2014an update on recent findings. Circ J. 2020;85:2\u20138. https:\/\/doi.org\/10.1253\/circj.CJ-20-0935.","journal-title":"Circ J"},{"key":"1126_CR3","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.2147\/jir.S350109","volume":"15","author":"M Wang","year":"2022","unstructured":"Wang M, Pan W, Xu Y, Zhang J, Wan J, Jiang H. Microglia-mediated neuroinflammation: a potential target for the treatment of cardiovascular diseases. J Inflamm Res. 2022;15:3083\u201394. https:\/\/doi.org\/10.2147\/jir.S350109.","journal-title":"J Inflamm Res"},{"key":"1126_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1161\/01.Atv.0000099786.99623.Ef","volume":"24","author":"Y Matsuzawa","year":"2004","unstructured":"Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004;24:29\u201333. https:\/\/doi.org\/10.1161\/01.Atv.0000099786.99623.Ef.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1126_CR5","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1093\/eurheartj\/ehad484","volume":"44","author":"C Antoniades","year":"2023","unstructured":"Antoniades C, Tousoulis D, Vavlukis M, Fleming I, Duncker DJ, Eringa E, et al. Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers. Eur Heart J. 2023;44:3827\u201344. https:\/\/doi.org\/10.1093\/eurheartj\/ehad484.","journal-title":"Eur Heart J"},{"key":"1126_CR6","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1113\/jp273049","volume":"595","author":"AS Antonopoulos","year":"2017","unstructured":"Antonopoulos AS, Antoniades C. The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles. J Physiol. 2017;595:3907\u201317. https:\/\/doi.org\/10.1113\/jp273049.","journal-title":"J Physiol"},{"key":"1126_CR7","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1253\/circj.CJ-24-0226","volume":"88","author":"T Kitagawa","year":"2024","unstructured":"Kitagawa T, Sentani K, Ikegami Y, Takasaki T, Takahashi S, Nakano Y. Relationship between clinical parameters and histological features of epicardial adipose tissue and aortic valve calcification assessed on computed tomography. Circ J. 2024;88:1986\u201395. https:\/\/doi.org\/10.1253\/circj.CJ-24-0226.","journal-title":"Circ J"},{"key":"1126_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1253\/circj.CJ-23-0808","volume":"88","author":"L Kuo","year":"2024","unstructured":"Kuo L, Wang GJ, Chang SL, Lin YJ, Chung FP, Lo LW, et al. Feasibility of auto-quantified epicardial adipose tissue in predicting atrial fibrillation recurrence after catheter ablation. Circ J. 2024;88:1089\u201398. https:\/\/doi.org\/10.1253\/circj.CJ-23-0808.","journal-title":"Circ J"},{"key":"1126_CR9","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1253\/circj.CJ-23-0474","volume":"88","author":"Z Wang","year":"2024","unstructured":"Wang Z, Li J, Chen J, Guo H, He H, Jiao S, et al. Relationship between epicardial adipose tissue volume and recurrence after ablation in premature ventricular complexes. Circ J. 2024;88:1047\u201354. https:\/\/doi.org\/10.1253\/circj.CJ-23-0474.","journal-title":"Circ J"},{"key":"1126_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1253\/circj.CJ-22-0196","volume":"87","author":"J Sakai","year":"2022","unstructured":"Sakai J, Takami M, Fukuzawa K, Kiuchi K, Nakamura T, Yatomi A, et al. Sex Differences in the regional analysis of nonpulmonary vein foci and epicardial adipose tissue in patients with atrial fibrillation. Circ J. 2022;87:29\u201340. https:\/\/doi.org\/10.1253\/circj.CJ-22-0196.","journal-title":"Circ J"},{"key":"1126_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1253\/circrep.CR-23-0073","volume":"5","author":"S Nakahara","year":"2023","unstructured":"Nakahara S, Hori Y, Fukuda R, Sato H, Aoki H, Ishikawa T, et al. Chronic effect of hotballoon-based wide planar ablation on epicardial adipose tissue in persistent atrial fibrillation. Circ Rep. 2023;5:371\u201380. https:\/\/doi.org\/10.1253\/circrep.CR-23-0073.","journal-title":"Circ Rep"},{"key":"1126_CR12","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/eurheartj\/ehz474","volume":"41","author":"C Antoniades","year":"2020","unstructured":"Antoniades C, Antonopoulos AS, Deanfield J. Imaging residual inflammatory cardiovascular risk. Eur Heart J. 2020;41:748\u201358. https:\/\/doi.org\/10.1093\/eurheartj\/ehz474.","journal-title":"Eur Heart J"},{"key":"1126_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2337\/db18-1066","volume":"69","author":"AH Turaihi","year":"2020","unstructured":"Turaihi AH, Sern\u00e9 EH, Molthoff CFM, Koning JJ, Knol J, Niessen HW, et al. Perivascular adipose tissue controls insulin-stimulated perfusion, mitochondrial protein expression, and glucose uptake in muscle through adipomuscular arterioles. Diabetes. 2020;69:603\u201313. https:\/\/doi.org\/10.2337\/db18-1066.","journal-title":"Diabetes"},{"key":"1126_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3389\/fphys.2018.00253","volume":"9","author":"RM Costa","year":"2018","unstructured":"Costa RM, Neves KB, Tostes RC, Lobato NS. Perivascular adipose tissue as a relevant fat depot for cardiovascular risk in obesity. Front Physiol. 2018;9:253. https:\/\/doi.org\/10.3389\/fphys.2018.00253.","journal-title":"Front Physiol"},{"key":"1126_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal2658","author":"AS Antonopoulos","year":"2017","unstructured":"Antonopoulos AS, Sanna F, Sabharwal N, Thomas S, Oikonomou EK, Herdman L, et al. Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aal2658.","journal-title":"Sci Transl Med"},{"key":"1126_CR16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1253\/circj.CJ-22-0740","volume":"87","author":"T Mikami","year":"2023","unstructured":"Mikami T, Furuhashi M, Numaguchi R, Hosaka I, Sakai A, Tanaka M, et al. Comparison of phenotypes in subcutaneous fat and perivascular adipose tissue surrounding the saphenous vein in coronary artery bypass grafting. Circ J. 2023;87:791\u20138. https:\/\/doi.org\/10.1253\/circj.CJ-22-0740.","journal-title":"Circ J"},{"key":"1126_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/vhrm.S33760","volume":"9","author":"T Szasz","year":"2013","unstructured":"Szasz T, Bomfim GF, Webb RC. The influence of perivascular adipose tissue on vascular homeostasis. Vasc Health Risk Manag. 2013;9:105\u201316. https:\/\/doi.org\/10.2147\/vhrm.S33760.","journal-title":"Vasc Health Risk Manag"},{"key":"1126_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/00033197221121617","volume":"74","author":"M Marketou","year":"2023","unstructured":"Marketou M, Kontaraki J, Kalogerakos P, Plevritaki A, Chlouverakis G, Kassotakis S, et al. Differences in microRNA expression in pericoronary adipose tissue in coronary artery disease compared to severe valve dysfunction. Angiology. 2023;74:22\u201330. https:\/\/doi.org\/10.1177\/00033197221121617.","journal-title":"Angiology"},{"key":"1126_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/cvr\/cvv266","volume":"109","author":"M Vacca","year":"2016","unstructured":"Vacca M, Di Eusanio M, Cariello M, Graziano G, D\u2019Amore S, Petridis FD, et al. Integrative miRNA and whole-genome analyses of epicardial adipose tissue in patients with coronary atherosclerosis. Cardiovasc Res. 2016;109:228\u201339. https:\/\/doi.org\/10.1093\/cvr\/cvv266.","journal-title":"Cardiovasc Res"},{"key":"1126_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2022.106968","volume":"143","author":"Y Liu","year":"2022","unstructured":"Liu Y, Sun Y, Lin X, Zhang D, Hu C, Liu J, et al. Perivascular adipose-derived exosomes reduce macrophage foam cell formation through miR-382-5p and the BMP4-PPAR\u03b3-ABCA1\/ABCG1 pathways. Vascul Pharmacol. 2022;143: 106968. https:\/\/doi.org\/10.1016\/j.vph.2022.106968.","journal-title":"Vascul Pharmacol"},{"key":"1126_CR21","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1161\/atvbaha.120.312470","volume":"40","author":"HW Kim","year":"2020","unstructured":"Kim HW, Shi H, Winkler MA, Lee R, Weintraub NL. Perivascular adipose tissue and vascular perturbation\/atherosclerosis. Arterioscler Thromb Vasc Biol. 2020;40:2569\u201376. https:\/\/doi.org\/10.1161\/atvbaha.120.312470.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1126_CR22","doi-asserted-by":"publisher","first-page":"364","DOI":"10.5551\/jat.63580","volume":"30","author":"K Ichikawa","year":"2023","unstructured":"Ichikawa K, Miyoshi T, Ohno Y, Osawa K, Nakashima M, Nishihara T, et al. Association between high pericoronary adipose tissue computed tomography attenuation and impaired flow-mediated dilation of the brachial artery. J Atheroscler Thromb. 2023;30:364\u201376. https:\/\/doi.org\/10.5551\/jat.63580.","journal-title":"J Atheroscler Thromb"},{"key":"1126_CR23","doi-asserted-by":"publisher","first-page":"H193","DOI":"10.1152\/ajpheart.00431.2009","volume":"299","author":"C Chen","year":"2010","unstructured":"Chen C, Jiang J, L\u00fc JM, Chai H, Wang X, Lin PH, et al. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol. 2010;299:H193-201. https:\/\/doi.org\/10.1152\/ajpheart.00431.2009.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1126_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41569-018-0097-6","volume":"16","author":"EK Oikonomou","year":"2019","unstructured":"Oikonomou EK, Antoniades C. The role of adipose tissue in cardiovascular health and disease. Nat Rev Cardiol. 2019;16:83\u201399. https:\/\/doi.org\/10.1038\/s41569-018-0097-6.","journal-title":"Nat Rev Cardiol"},{"key":"1126_CR25","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/01.Cir.0000143233.87854.23","volume":"110","author":"PR Moreno","year":"2004","unstructured":"Moreno PR, Purushothaman KR, Fuster V, Echeverri D, Truszczynska H, Sharma SK, et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation. 2004;110:2032\u20138. https:\/\/doi.org\/10.1161\/01.Cir.0000143233.87854.23.","journal-title":"Circulation"},{"key":"1126_CR26","doi-asserted-by":"publisher","first-page":"eabl6364","DOI":"10.1126\/sciadv.abl6364","volume":"8","author":"JA Phillippi","year":"2022","unstructured":"Phillippi JA. On vasa vasorum: a history of advances in understanding the vessels of vessels. Sci Adv. 2022;8:eabl6364. https:\/\/doi.org\/10.1126\/sciadv.abl6364.","journal-title":"Sci Adv"},{"key":"1126_CR27","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.jacc.2008.12.056","volume":"53","author":"JC Sluimer","year":"2009","unstructured":"Sluimer JC, Kolodgie FD, Bijnens AP, Maxfield K, Pacheco E, Kutys B, et al. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol. 2009;53:1517\u201327. https:\/\/doi.org\/10.1016\/j.jacc.2008.12.056.","journal-title":"J Am Coll Cardiol"},{"key":"1126_CR28","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.ahj.2007.03.019","volume":"153","author":"HS Sacks","year":"2007","unstructured":"Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007;153:907\u201317. https:\/\/doi.org\/10.1016\/j.ahj.2007.03.019.","journal-title":"Am Heart J"},{"key":"1126_CR29","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1161\/01.Cir.0000099542.57313.C5","volume":"108","author":"T Mazurek","year":"2003","unstructured":"Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460\u20136. https:\/\/doi.org\/10.1161\/01.Cir.0000099542.57313.C5.","journal-title":"Circulation"},{"key":"1126_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jacc.2011.01.048","volume":"58","author":"Y Hirata","year":"2011","unstructured":"Hirata Y, Tabata M, Kurobe H, Motoki T, Akaike M, Nishio C, et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol. 2011;58:248\u201355. https:\/\/doi.org\/10.1016\/j.jacc.2011.01.048.","journal-title":"J Am Coll Cardiol"},{"key":"1126_CR31","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/atvbaha.112.300829","volume":"33","author":"M Shimabukuro","year":"2013","unstructured":"Shimabukuro M, Hirata Y, Tabata M, Dagvasumberel M, Sato H, Kurobe H, et al. Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2013;33:1077\u201384. https:\/\/doi.org\/10.1161\/atvbaha.112.300829.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1126_CR32","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1253\/circj.CJ-19-0914","volume":"84","author":"H Ito","year":"2020","unstructured":"Ito H, Wakatsuki T, Yamaguchi K, Fukuda D, Kawabata Y, Matsuura T, et al. Atherosclerotic coronary plaque is associated with adventitial vasa vasorum and local inflammation in adjacent epicardial adipose tissue in fresh cadavers. Circ J. 2020;84:769\u201375. https:\/\/doi.org\/10.1253\/circj.CJ-19-0914.","journal-title":"Circ J"},{"key":"1126_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1253\/circj.CJ-22-0299","volume":"87","author":"Y Kawabata","year":"2023","unstructured":"Kawabata Y, Wakatsuki T, Yamaguchi K, Fukuda D, Ito H, Matsuura T, et al. Association of microluminal structures assessed by optical coherence tomography with local inflammation in adjacent epicardial adipose tissue and coronary plaque characteristics in fresh cadavers. Circ J. 2023;87:329\u201335. https:\/\/doi.org\/10.1253\/circj.CJ-22-0299.","journal-title":"Circ J"},{"key":"1126_CR34","doi-asserted-by":"publisher","first-page":"e773","DOI":"10.1016\/j.jacl.2024.06.006","volume":"18","author":"M Amangurbanova","year":"2024","unstructured":"Amangurbanova M, Daher R, Asbeutah AA, Vemuri B, Mirza H, Waseem S, et al. Higher epicardial adipose tissue volume is associated with higher coronary fatty plaque volume and is regulated by waist circumference but not EPA+DHA supplementation. J Clin Lipidol. 2024;18:e773\u201386. https:\/\/doi.org\/10.1016\/j.jacl.2024.06.006.","journal-title":"J Clin Lipidol"},{"key":"1126_CR35","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jacc.2012.11.062","volume":"61","author":"AA Mahabadi","year":"2013","unstructured":"Mahabadi AA, Berg MH, Lehmann N, K\u00e4lsch H, Bauer M, Kara K, et al. Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall Study. J Am Coll Cardiol. 2013;61:1388\u201395. https:\/\/doi.org\/10.1016\/j.jacc.2012.11.062.","journal-title":"J Am Coll Cardiol"},{"key":"1126_CR36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12933-019-0917-y","volume":"18","author":"RH Christensen","year":"2019","unstructured":"Christensen RH, von Scholten BJ, Hansen CS, Jensen MT, Vilsb\u00f8ll T, Rossing P, et al. Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes. Cardiovasc Diabetol. 2019;18:114. https:\/\/doi.org\/10.1186\/s12933-019-0917-y.","journal-title":"Cardiovasc Diabetol"},{"key":"1126_CR37","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1093\/cvr\/cvz321","volume":"116","author":"F Commandeur","year":"2020","unstructured":"Commandeur F, Slomka PJ, Goeller M, Chen X, Cadet S, Razipour A, et al. Machine learning to predict the long-term risk of myocardial infarction and cardiac death based on clinical risk, coronary calcium, and epicardial adipose tissue: a prospective study. Cardiovasc Res. 2020;116:2216\u201325. https:\/\/doi.org\/10.1093\/cvr\/cvz321.","journal-title":"Cardiovasc Res"},{"key":"1126_CR38","doi-asserted-by":"publisher","DOI":"10.1161\/circimaging.119.009829","volume":"13","author":"E Eisenberg","year":"2020","unstructured":"Eisenberg E, McElhinney PA, Commandeur F, Chen X, Cadet S, Goeller M, et al. Deep learning-based quantification of epicardial adipose tissue volume and attenuation predicts major adverse cardiovascular events in asymptomatic subjects. Circ Cardiovasc Imaging. 2020;13: e009829. https:\/\/doi.org\/10.1161\/circimaging.119.009829.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1126_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2024.100711","volume":"19","author":"A Filtz","year":"2024","unstructured":"Filtz A, Lorenzatti D, Scotti A, Pi\u00f1a P, Fernandez-Hazim C, Huang D, et al. Relationship between epicardial adipose tissue and coronary atherosclerosis by CCTA in young adults (18\u201345). Am J Prev Cardiol. 2024;19: 100711. https:\/\/doi.org\/10.1016\/j.ajpc.2024.100711.","journal-title":"Am J Prev Cardiol"},{"key":"1126_CR40","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1001\/jamacardio.2024.0080","volume":"9","author":"JT R\u00e4m\u00f6","year":"2024","unstructured":"R\u00e4m\u00f6 JT, Kany S, Hou CR, Friedman SF, Roselli C, Nauffal V, et al. Cardiovascular significance and genetics of epicardial and pericardial adiposity. JAMA Cardiol. 2024;9:418\u201327. https:\/\/doi.org\/10.1001\/jamacardio.2024.0080.","journal-title":"JAMA Cardiol"},{"key":"1126_CR41","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12933-024-02411-y","volume":"23","author":"B Gaborit","year":"2024","unstructured":"Gaborit B, Julla JB, Fournel J, Ancel P, Soghomonian A, Deprade C, et al. Fully automated epicardial adipose tissue volume quantification with deep learning and relationship with CAC score and micro\/macrovascular complications in people living with type 2 diabetes: the multicenter EPIDIAB study. Cardiovasc Diabetol. 2024;23:328. https:\/\/doi.org\/10.1186\/s12933-024-02411-y.","journal-title":"Cardiovasc Diabetol"},{"key":"1126_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.117549","volume":"397","author":"M Guglielmo","year":"2024","unstructured":"Guglielmo M, Penso M, Carerj ML, Giacari CM, Volpe A, Fusini L, et al. Deep learning-based quantification of epicardial adipose tissue predicts MACE in patients undergoing stress CMR. Atherosclerosis. 2024;397: 117549. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117549.","journal-title":"Atherosclerosis"},{"key":"1126_CR43","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3390\/tomography8040147","volume":"8","author":"P Theofilis","year":"2022","unstructured":"Theofilis P, Sagris M, Antonopoulos AS, Oikonomou E, Tsioufis K, Tousoulis D. Non-invasive modalities in the assessment of vulnerable coronary atherosclerotic plaques. Tomography. 2022;8:1742\u201358. https:\/\/doi.org\/10.3390\/tomography8040147.","journal-title":"Tomography"},{"key":"1126_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12933-024-02199-x","volume":"23","author":"Y Liu","year":"2024","unstructured":"Liu Y, Dai L, Dong Y, Ma C, Cheng P, Jiang C, et al. Coronary inflammation based on pericoronary adipose tissue attenuation in type 2 diabetic mellitus: effect of diabetes management. Cardiovasc Diabetol. 2024;23:108. https:\/\/doi.org\/10.1186\/s12933-024-02199-x.","journal-title":"Cardiovasc Diabetol"},{"key":"1126_CR45","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.2147\/ijgm.S468768","volume":"17","author":"YS Feng","year":"2024","unstructured":"Feng YS, Sun ZY, Jiang F, Ma PC, Liu XR, Meng YY, et al. Association between pericoronary fat attenuation index as evaluated by coronary artery CT angiography and clinical interventions in lipid management among patients with coronary artery disease. Int J Gen Med. 2024;17:4937\u201346. https:\/\/doi.org\/10.2147\/ijgm.S468768.","journal-title":"Int J Gen Med"},{"key":"1126_CR46","doi-asserted-by":"publisher","first-page":"1303529","DOI":"10.3389\/fcvm.2024.1303529","volume":"11","author":"M Chen","year":"2024","unstructured":"Chen M, Liu B, Li X, Li D, Fan L. Relationship between peri-coronary inflammation and coronary vascular function in patients with suspected coronary artery disease. Front Cardiovasc Med. 2024;11:1303529. https:\/\/doi.org\/10.3389\/fcvm.2024.1303529.","journal-title":"Front Cardiovasc Med"},{"key":"1126_CR47","doi-asserted-by":"publisher","first-page":"e526","DOI":"10.1093\/ehjci\/jeac174","volume":"23","author":"M Sagris","year":"2022","unstructured":"Sagris M, Antonopoulos AS, Simantiris S, Oikonomou E, Siasos G, Tsioufis K, et al. Pericoronary fat attenuation index-a new imaging biomarker and its diagnostic and prognostic utility: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging. 2022;23:e526\u201336. https:\/\/doi.org\/10.1093\/ehjci\/jeac174.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1126_CR48","doi-asserted-by":"publisher","DOI":"10.1161\/circimaging.122.015135","volume":"16","author":"AS Antonopoulos","year":"2023","unstructured":"Antonopoulos AS, Simantiris S. Detecting the vulnerable patient: toward preventive imaging by coronary computed tomography angiography. Circ Cardiovasc Imaging. 2023;16: e015135. https:\/\/doi.org\/10.1161\/circimaging.122.015135.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1126_CR49","doi-asserted-by":"publisher","DOI":"10.1161\/circimaging.122.014672","volume":"16","author":"JH Kuneman","year":"2023","unstructured":"Kuneman JH, van Rosendael SE, van der Bijl P, van Rosendael AR, Kitslaar PH, Reiber JHC, et al. Pericoronary adipose tissue attenuation in patients with acute coronary syndrome versus stable coronary artery disease. Circ Cardiovasc Imaging. 2023;16: e014672. https:\/\/doi.org\/10.1161\/circimaging.122.014672.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1126_CR50","doi-asserted-by":"publisher","first-page":"1451807","DOI":"10.3389\/fcvm.2024.1451807","volume":"11","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang H, Wang Z, Liu W, Cao D, Tong Q. Evaluating the role of pericoronary adipose tissue on coronary artery disease: insights from CCTA on risk assessment, vascular stenosis, and plaque characteristics. Front Cardiovasc Med. 2024;11:1451807. https:\/\/doi.org\/10.3389\/fcvm.2024.1451807.","journal-title":"Front Cardiovasc Med"},{"key":"1126_CR51","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1093\/bjr\/tqae135","volume":"97","author":"W He","year":"2024","unstructured":"He W, Lu Y, Yin J, He F, Zhang Y, Qiao G, et al. Coronary computed tomography angiography-derived fat attenuation index predict future percutaneous coronary intervention. Br J Radiol. 2024;97:1782\u201390. https:\/\/doi.org\/10.1093\/bjr\/tqae135.","journal-title":"Br J Radiol"},{"key":"1126_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.822308","volume":"9","author":"B Qin","year":"2022","unstructured":"Qin B, Li Z, Zhou H, Liu Y, Wu H, Wang Z. The predictive value of the perivascular adipose tissue CT fat attenuation index for coronary in-stent restenosis. Front Cardiovasc Med. 2022;9: 822308. https:\/\/doi.org\/10.3389\/fcvm.2022.822308.","journal-title":"Front Cardiovasc Med"},{"key":"1126_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-024-01709-x","author":"S Huang","year":"2024","unstructured":"Huang S, Yu X, Yang B, Xu T, Gu H, Wang X. Predictive value of pericoronary fat attenuation index for graft occlusion after coronary artery bypass grafting. Jpn J Radiol. 2024. https:\/\/doi.org\/10.1007\/s11604-024-01709-x.","journal-title":"Jpn J Radiol"},{"key":"1126_CR54","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/s12872-024-04257-4","volume":"24","author":"L Han","year":"2024","unstructured":"Han L, Like L, Wang M, Zhou M, Xu Z, Yan F, et al. Investigating the peri-saphenous vein graft fat attenuation index on computed tomography angiography: relationship with progression of venous coronary artery bypass graft disease and temporal trends. BMC Cardiovasc Disord. 2024;24:597. https:\/\/doi.org\/10.1186\/s12872-024-04257-4.","journal-title":"BMC Cardiovasc Disord"},{"key":"1126_CR55","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1093\/eurheartj\/ehz592","volume":"40","author":"EK Oikonomou","year":"2019","unstructured":"Oikonomou EK, Williams MC, Kotanidis CP, Desai MY, Marwan M, Antonopoulos AS, et al. A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography. Eur Heart J. 2019;40:3529\u201343. https:\/\/doi.org\/10.1093\/eurheartj\/ehz592.","journal-title":"Eur Heart J"},{"key":"1126_CR56","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/s0140-6736(18)31114-0","volume":"392","author":"EK Oikonomou","year":"2018","unstructured":"Oikonomou EK, Marwan M, Desai MY, Mancio J, Alashi A, Hutt Centeno E, et al. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet. 2018;392:929\u201339. https:\/\/doi.org\/10.1016\/s0140-6736(18)31114-0.","journal-title":"Lancet"},{"key":"1126_CR57","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1016\/s0140-6736(24)00596-8","volume":"403","author":"K Chan","year":"2024","unstructured":"Chan K, Wahome E, Tsiachristas A, Antonopoulos AS, Patel P, Lyasheva M, et al. Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study. Lancet. 2024;403:2606\u201318. https:\/\/doi.org\/10.1016\/s0140-6736(24)00596-8.","journal-title":"Lancet"},{"key":"1126_CR58","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12933-022-01478-9","volume":"21","author":"K Ichikawa","year":"2022","unstructured":"Ichikawa K, Miyoshi T, Osawa K, Nakashima M, Miki T, Nishihara T, et al. High pericoronary adipose tissue attenuation on computed tomography angiography predicts cardiovascular events in patients with type 2 diabetes mellitus: post-hoc analysis from a prospective cohort study. Cardiovasc Diabetol. 2022;21:44. https:\/\/doi.org\/10.1186\/s12933-022-01478-9.","journal-title":"Cardiovasc Diabetol"},{"key":"1126_CR59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.hjc.2022.07.004","volume":"67","author":"S Kato","year":"2022","unstructured":"Kato S, Utsunomiya D, Horita N, Hoshino M, Kakuta T. Prognostic significance of the perivascular fat attenuation index derived by coronary computed tomography: a meta-analysis. Hellenic J Cardiol. 2022;67:73\u20135. https:\/\/doi.org\/10.1016\/j.hjc.2022.07.004.","journal-title":"Hellenic J Cardiol"},{"key":"1126_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcct.2024.10.013","author":"YJ Choi","year":"2024","unstructured":"Choi YJ, Yang S, West H, Tomlins P, Hoshino M, Murai T, et al. Association of coronary inflammation with plaque vulnerability and fractional flow reserve in coronary artery disease. J Cardiovasc Comput Tomogr. 2024. https:\/\/doi.org\/10.1016\/j.jcct.2024.10.013.","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"1126_CR61","doi-asserted-by":"publisher","first-page":"1462451","DOI":"10.3389\/fcvm.2024.1462451","volume":"11","author":"W Zhan","year":"2024","unstructured":"Zhan W, Luo Y, Luo H, Zhou Z, Yin N, Li Y, et al. Predicting major adverse cardiovascular events in angina patients using radiomic features of pericoronary adipose tissue based on CCTA. Front Cardiovasc Med. 2024;11:1462451. https:\/\/doi.org\/10.3389\/fcvm.2024.1462451.","journal-title":"Front Cardiovasc Med"},{"key":"1126_CR62","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.crad.2024.08.018","volume":"79","author":"W Yang","year":"2024","unstructured":"Yang W, Ding X, Yu Y, Lan Z, Yu L, Yuan J, et al. Long-term prognostic value of CT-based high-risk coronary lesion attributes and radiomic features of pericoronary adipose tissue in diabetic patients. Clin Radiol. 2024;79:931\u201340. https:\/\/doi.org\/10.1016\/j.crad.2024.08.018.","journal-title":"Clin Radiol"},{"key":"1126_CR63","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1093\/ehjci\/jeae197","volume":"25","author":"SE van Rosendael","year":"2024","unstructured":"van Rosendael SE, Kamperidis V, Maaniitty T, de Graaf MA, Saraste A, McKay-Goodall GE, et al. Pericoronary adipose tissue for predicting long-term outcomes. Eur Heart J Cardiovasc Imaging. 2024;25:1351\u20139. https:\/\/doi.org\/10.1093\/ehjci\/jeae197.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1126_CR64","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12933-024-02272-5","volume":"23","author":"M Liu","year":"2024","unstructured":"Liu M, Zhen Y, Shang J, Dang Y, Zhang Q, Ni W, et al. The predictive value of lesion-specific pericoronary fat attenuation index for major adverse cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2024;23:191. https:\/\/doi.org\/10.1186\/s12933-024-02272-5.","journal-title":"Cardiovasc Diabetol"},{"key":"1126_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-089047","volume":"14","author":"L Baskaran","year":"2024","unstructured":"Baskaran L, Leng S, Dutta U, Teo L, Yew MS, Sia CH, et al. Cohort profile: AI-driven national platform for CCTA for clinical and industrial applications (APOLLO). BMJ Open. 2024;14: e089047. https:\/\/doi.org\/10.1136\/bmjopen-2024-089047.","journal-title":"BMJ Open"},{"key":"1126_CR66","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1161\/circulationaha.119.042287","volume":"140","author":"RH Christensen","year":"2019","unstructured":"Christensen RH, Lehrskov LL, Wedell-Neergaard AS, Legaard GE, Ried-Larsen M, Karstoft K, et al. Aerobic exercise induces cardiac fat loss and alters cardiac muscle mass through an interleukin-6 receptor-dependent mechanism: cardiac analysis of a double-blind randomized controlled clinical trial in abdominally obese humans. Circulation. 2019;140:1684\u20136. https:\/\/doi.org\/10.1161\/circulationaha.119.042287.","journal-title":"Circulation"},{"key":"1126_CR67","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s10741-020-09965-5","volume":"26","author":"T Colonetti","year":"2021","unstructured":"Colonetti T, Grande AJ, Amaral MC, Colonetti L, Uggioni ML, da Rosa MI, et al. Effect of exercise on epicardial adipose tissue in adults: a systematic review and meta-analyses. Heart Fail Rev. 2021;26:1399\u2013411. https:\/\/doi.org\/10.1007\/s10741-020-09965-5.","journal-title":"Heart Fail Rev"},{"key":"1126_CR68","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1253\/circj.CJ-21-0615","volume":"86","author":"S Motoyama","year":"2022","unstructured":"Motoyama S, Nagahara Y, Sarai M, Kawai H, Miyajima K, Sato Y, et al. Effect of omega-3 fatty acids on coronary plaque morphology\u2014a serial computed tomography angiography study. Circ J. 2022;86:831\u201342. https:\/\/doi.org\/10.1253\/circj.CJ-21-0615.","journal-title":"Circ J"},{"key":"1126_CR69","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1253\/circj.CJ-21-0869","volume":"86","author":"M Watanabe","year":"2022","unstructured":"Watanabe M, Aonuma K, Murohara T, Okumura Y, Morimoto T, Okada S, et al. Prevention of contrast-induced nephropathy after cardiovascular catheterization and intervention with high-dose strong statin therapy in Japan\u2014The PREVENT CINC-J Study. Circ J. 2022;86:1455\u201363. https:\/\/doi.org\/10.1253\/circj.CJ-21-0869.","journal-title":"Circ J"},{"key":"1126_CR70","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1253\/circj.CJ-22-0315","volume":"86","author":"M Natsuaki","year":"2022","unstructured":"Natsuaki M, Morimoto T, Iimuro S, Fujita R, Iwata H, Miyauchi K, et al. Thrombotic risk stratification and intensive statin therapy for secondary prevention of coronary artery disease\u2014insights from the REAL-CAD study. Circ J. 2022;86:1416\u201327. https:\/\/doi.org\/10.1253\/circj.CJ-22-0315.","journal-title":"Circ J"},{"key":"1126_CR71","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1253\/circj.CJ-22-0168","volume":"87","author":"T Toyota","year":"2023","unstructured":"Toyota T, Morimoto T, Iimuro S, Fujita R, Iwata H, Miyauchi K, et al. Low-density lipoprotein cholesterol levels on statins and cardiovascular event risk in stable coronary artery disease\u2014an observation from the REAL-CAD study. Circ J. 2023;87:360\u20137. https:\/\/doi.org\/10.1253\/circj.CJ-22-0168.","journal-title":"Circ J"},{"key":"1126_CR72","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1253\/circj.CJ-22-0650","volume":"87","author":"H Watanabe","year":"2023","unstructured":"Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Natsuaki M, Yamaji K, et al. Prevalence and effects of high-intensity statins for japanese patients presenting with acute coronary syndrome\u2014a post hoc secondary analysis of STOPDAPT-2 ACS. Circ J. 2023;87:657\u201368. https:\/\/doi.org\/10.1253\/circj.CJ-22-0650.","journal-title":"Circ J"},{"key":"1126_CR73","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1253\/circj.CJ-23-0134","volume":"88","author":"T Higuma","year":"2024","unstructured":"Higuma T, Akashi YJ, Fukumoto Y, Obara H, Kakuma T, Asaumi Y, et al. Residual coronary risk factors associated with long-term clinical outcomes in patients with coronary artery disease treated with high- vs. low-dose statin therapy\u2014REAL-CAD substudy. Circ J. 2024;88:995\u20131003. https:\/\/doi.org\/10.1253\/circj.CJ-23-0134.","journal-title":"Circ J"},{"key":"1126_CR74","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1253\/circj.CJ-23-0694","volume":"88","author":"A Nohara","year":"2024","unstructured":"Nohara A. The worst combination for coronary artery disease under strong-statin therapy is chronic kidney disease and diabetes\u2014non-lipid residual risk assessment from the REAL-CAD study. Circ J. 2024;88:1004\u20136. https:\/\/doi.org\/10.1253\/circj.CJ-23-0694.","journal-title":"Circ J"},{"key":"1126_CR75","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1253\/circj.CJ-23-0837","volume":"88","author":"K Nishihira","year":"2024","unstructured":"Nishihira K, Nakai M, Kuriyama N, Kadooka K, Honda Y, Emori H, et al. Guideline-directed medical therapy for elderly patients with acute myocardial infarction who undergo percutaneous coronary intervention\u2014insights from a retrospective observational study. Circ J. 2024;88:931\u20137. https:\/\/doi.org\/10.1253\/circj.CJ-23-0837.","journal-title":"Circ J"},{"key":"1126_CR76","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1253\/circj.CJ-23-0814","volume":"88","author":"F Sheng","year":"2024","unstructured":"Sheng F, Wang AY, Miyawaki K, Tsuchiya T, Osada N, Miller R, et al. Real-world clinical profile of patients prescribed evolocumab in Japan. Circ J. 2024;88:1629\u201336. https:\/\/doi.org\/10.1253\/circj.CJ-23-0814.","journal-title":"Circ J"},{"key":"1126_CR77","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1253\/circj.CJ-24-0242","volume":"88","author":"T Akiyama","year":"2024","unstructured":"Akiyama T, Ikegami R, Kubota N, Takano T, Yoneyama S, Okubo T, et al. Serum apolipoprotein-A2 levels are a strong predictor of future cardiovascular events in patients undergoing percutaneous coronary intervention. Circ J. 2024;88:1770\u20137. https:\/\/doi.org\/10.1253\/circj.CJ-24-0242.","journal-title":"Circ J"},{"key":"1126_CR78","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1253\/circj.CJ-24-0536","volume":"88","author":"M Yoshikawa","year":"2024","unstructured":"Yoshikawa M, Honda A, Arashi H, Shibahashi E, Otsuki H, Kawada-Watanabe E, et al. Addition of ezetimibe to intensive lipid-lowering therapy is associated with a lower incidence of heart failure in patients with acute coronary syndrome. Circ J. 2024;88:1819\u201324. https:\/\/doi.org\/10.1253\/circj.CJ-24-0536.","journal-title":"Circ J"},{"key":"1126_CR79","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1253\/circj.CJ-24-0480","volume":"88","author":"T Yamamoto","year":"2024","unstructured":"Yamamoto T, Sugizaki Y, Kawamori H, Toba T, Hiromasa T, Sasaki S, et al. Enhanced plaque stabilization effects of alirocumab\u2014insights from artificial intelligence-aided optical coherence tomography analysis of the alirocumab for thin-cap fibroatheroma in patients with coronary artery disease estimated by optical coherence tomography (ALTAIR) study. Circ J. 2024;88:1809\u201318. https:\/\/doi.org\/10.1253\/circj.CJ-24-0480.","journal-title":"Circ J"},{"key":"1126_CR80","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1253\/circrep.CR-22-0070","volume":"4","author":"K Wakabayashi","year":"2022","unstructured":"Wakabayashi K, Suzuki H, Fukumoto Y, Obara H, Kakuma T, Sakuma I, et al. comorbidities associated with residual cardiovascular risk in patients with chronic coronary syndrome receiving statin therapy\u2014subanalysis of the REAL-CAD trial. Circ Rep. 2022;4:422\u20138. https:\/\/doi.org\/10.1253\/circrep.CR-22-0070.","journal-title":"Circ Rep"},{"key":"1126_CR81","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1253\/circrep.CR-23-0038","volume":"5","author":"D Nose","year":"2023","unstructured":"Nose D, Shiga Y, Takahashi RU, Yamamoto Y, Suematsu Y, Kuwano T, et al. Association between telomere G-tail length and coronary artery disease or statin treatment in patients with cardiovascular risks\u2014a cross-sectional study. Circ Rep. 2023;5:338\u201347. https:\/\/doi.org\/10.1253\/circrep.CR-23-0038.","journal-title":"Circ Rep"},{"key":"1126_CR82","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1253\/circrep.CR-23-0071","volume":"5","author":"T Mitsui","year":"2023","unstructured":"Mitsui T, Bando YK, Hirakawa A, Furusawa K, Morimoto R, Taguchi E, et al. Role of common antihypertensives in the growth of abdominal aortic aneurysm at the presurgical stage. Circ Rep. 2023;5:405\u201314. https:\/\/doi.org\/10.1253\/circrep.CR-23-0071.","journal-title":"Circ Rep"},{"key":"1126_CR83","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1253\/circrep.CR-24-0071","volume":"7","author":"K Seiyama","year":"2025","unstructured":"Seiyama K, Oka A, Miyoshi T, Sudo Y, Takagi W, Ugawa S, et al. Impact of an intensive lipid-lowering therapy protocol on achieving target low-density lipoprotein cholesterol levels in patients with acute coronary syndrome. Circ Rep. 2025;7:131\u20138. https:\/\/doi.org\/10.1253\/circrep.CR-24-0071.","journal-title":"Circ Rep"},{"key":"1126_CR84","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.jacc.2012.12.051","volume":"61","author":"N Alexopoulos","year":"2013","unstructured":"Alexopoulos N, Melek BH, Arepalli CD, Hartlage GR, Chen Z, Kim S, et al. Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (beyond endorsed lipid lowering with EBT scanning). J Am Coll Cardiol. 2013;61:1956\u201361. https:\/\/doi.org\/10.1016\/j.jacc.2012.12.051.","journal-title":"J Am Coll Cardiol"},{"key":"1126_CR85","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ijcard.2020.06.008","volume":"319","author":"X Dai","year":"2020","unstructured":"Dai X, Yu L, Lu Z, Shen C, Tao X, Zhang J. Serial change of perivascular fat attenuation index after statin treatment: insights from a coronary CT angiography follow-up study. Int J Cardiol. 2020;319:144\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2020.06.008.","journal-title":"Int J Cardiol"},{"key":"1126_CR86","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1253\/circj.CJ-22-0105","volume":"86","author":"T Nakatsukasa","year":"2022","unstructured":"Nakatsukasa T, Ishizu T, Ouchi M, Murakoshi N, Sato K, Yamamoto M, et al. Sodium glucose co-transporter 2 inhibitors improve renal congestion and left ventricular fibrosis in rats with hypertensive heart failure. Circ J. 2022;86:2029\u201339. https:\/\/doi.org\/10.1253\/circj.CJ-22-0105.","journal-title":"Circ J"},{"key":"1126_CR87","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1253\/circj.CJ-22-0086","volume":"86","author":"S Kodera","year":"2022","unstructured":"Kodera S, Morita H, Nishi H, Takeda N, Ando J, Komuro I. Cost-effectiveness of dapagliflozin for chronic kidney disease in Japan. Circ J. 2022;86:2021\u20138. https:\/\/doi.org\/10.1253\/circj.CJ-22-0086.","journal-title":"Circ J"},{"key":"1126_CR88","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1253\/circrep.CR-22-0118","volume":"5","author":"R Matsukawa","year":"2023","unstructured":"Matsukawa R, Okahara A, Tokutome M, Itonaga J, Hara A, Kisanuki H, et al. Early initiation of sodium-glucose cotransporter 2 inhibitor leads to a shorter hospital stay in patients with acute decompensated heart failure. Circ Rep. 2023;5:187\u201397. https:\/\/doi.org\/10.1253\/circrep.CR-22-0118.","journal-title":"Circ Rep"},{"key":"1126_CR89","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1253\/circrep.CR-21-0030","volume":"3","author":"T Ueda","year":"2021","unstructured":"Ueda T, Kasama S, Yamamoto M, Nakano T, Ueshima K, Morikawa Y, et al. Effect of the sodium-glucose cotransporter 2 inhibitor canagliflozin for heart failure with preserved ejection fraction in patients with type 2 diabetes. Circ Rep. 2021;3:440\u20138. https:\/\/doi.org\/10.1253\/circrep.CR-21-0030.","journal-title":"Circ Rep"},{"key":"1126_CR90","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-24-0799","author":"H Motoki","year":"2025","unstructured":"Motoki H, Masuda I, Oba K, Yasuno S, Inobe Y, Azuma N, et al. Investigation of the effect of empagliflozin on cardiac sympathetic and parasympathetic nerve activity analyzed from heart rate variability frequency in Japanese patients with type 2 diabetes\u2014results from the EMPYREAN study. Circ J. 2025. https:\/\/doi.org\/10.1253\/circj.CJ-24-0799.","journal-title":"Circ J"},{"key":"1126_CR91","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1253\/circj.CJ-16-1148","volume":"81","author":"K Kaku","year":"2017","unstructured":"Kaku K, Lee J, Mattheus M, Kaspers S, George J, Woerle HJ. Empagliflozin and cardiovascular outcomes in asian patients with type 2 diabetes and established cardiovascular disease\u2014results from EMPA-REG OUTCOME(\u00ae). Circ J. 2017;81:227\u201334. https:\/\/doi.org\/10.1253\/circj.CJ-16-1148.","journal-title":"Circ J"},{"key":"1126_CR92","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1253\/circj.CJ-23-0864","volume":"88","author":"K Matsuda","year":"2024","unstructured":"Matsuda K, Mitsuo H, Nishijima T, Uchiyama H, Nita T, Matsunaga S, et al. Acute dapagliflozin administration ameliorates cardiac surgery-associated acute kidney injury in a rabbit model. Circ J. 2024;88:1488\u201398. https:\/\/doi.org\/10.1253\/circj.CJ-23-0864.","journal-title":"Circ J"},{"key":"1126_CR93","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1253\/circj.CJ-20-0341","volume":"84","author":"H Kayano","year":"2020","unstructured":"Kayano H, Koba S, Hirano T, Matsui T, Fukuoka H, Tsuijita H, et al. Dapagliflozin influences ventricular hemodynamics and exercise-induced pulmonary hypertension in type 2 diabetes patients\u2014a randomized controlled trial. Circ J. 2020;84:1807\u201317. https:\/\/doi.org\/10.1253\/circj.CJ-20-0341.","journal-title":"Circ J"},{"key":"1126_CR94","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1253\/circrep.CR-19-0070","volume":"1","author":"M Nakagaito","year":"2019","unstructured":"Nakagaito M, Joho S, Ushijima R, Nakamura M, Kinugawa K. Comparison of canagliflozin, dapagliflozin and empagliflozin added to heart failure treatment in decompensated heart failure patients with type 2 diabetes mellitus. Circ Rep. 2019;1:405\u201313. https:\/\/doi.org\/10.1253\/circrep.CR-19-0070.","journal-title":"Circ Rep"},{"key":"1126_CR95","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1253\/circrep.CR-21-0048","volume":"3","author":"A Shirakabe","year":"2021","unstructured":"Shirakabe A, Matsushita M, Okajima F, Asai K, Shimizu W. Effect of empagliflozin in preventing progression of renal dysfunction in diabetic patients with compensated heart failure\u2014reply. Circ Rep. 2021;3:359. https:\/\/doi.org\/10.1253\/circrep.CR-21-0048.","journal-title":"Circ Rep"},{"key":"1126_CR96","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1253\/circrep.CR-20-0142","volume":"3","author":"T Imamura","year":"2021","unstructured":"Imamura T. Effect of empagliflozin in preventing progression of renal dysfunction in diabetic patients with compensated heart failure. Circ Rep. 2021;3:358. https:\/\/doi.org\/10.1253\/circrep.CR-20-0142.","journal-title":"Circ Rep"},{"key":"1126_CR97","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1253\/circrep.CR-20-0041","volume":"2","author":"A Shirakabe","year":"2020","unstructured":"Shirakabe A, Matsushita M, Kiuchi K, Okazaki H, Inami T, Takayasu T, et al. Empagliflozin administration can decrease the dose of loop diuretics and prevent the exacerbation of renal tubular injury in patients with compensated heart failure complicated by diabetes. Circ Rep. 2020;2:565\u201375. https:\/\/doi.org\/10.1253\/circrep.CR-20-0041.","journal-title":"Circ Rep"},{"key":"1126_CR98","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jacbts.2023.05.007","volume":"8","author":"M Takano","year":"2023","unstructured":"Takano M, Kondo H, Harada T, Takahashi M, Ishii Y, Yamasaki H, et al. Empagliflozin suppresses the differentiation\/maturation of human epicardial preadipocytes and improves paracrine secretome profile. JACC Basic Transl Sci. 2023;8:1081\u201397. https:\/\/doi.org\/10.1016\/j.jacbts.2023.05.007.","journal-title":"JACC Basic Transl Sci"},{"key":"1126_CR99","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13098-017-0275-4","volume":"9","author":"S Yagi","year":"2017","unstructured":"Yagi S, Hirata Y, Ise T, Kusunose K, Yamada H, Fukuda D, et al. Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus. Diabetol Metab Syndr. 2017;9:78. https:\/\/doi.org\/10.1186\/s13098-017-0275-4.","journal-title":"Diabetol Metab Syndr"},{"key":"1126_CR100","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s13300-017-0279-y","volume":"8","author":"T Fukuda","year":"2017","unstructured":"Fukuda T, Bouchi R, Terashima M, Sasahara Y, Asakawa M, Takeuchi T, et al. Ipragliflozin reduces epicardial fat accumulation in non-obese type 2 diabetic patients with visceral obesity: a pilot study. Diabetes Ther. 2017;8:851\u201361. https:\/\/doi.org\/10.1007\/s13300-017-0279-y.","journal-title":"Diabetes Ther"},{"key":"1126_CR101","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12933-017-0516-8","volume":"16","author":"R Bouchi","year":"2017","unstructured":"Bouchi R, Terashima M, Sasahara Y, Asakawa M, Fukuda T, Takeuchi T, et al. Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study. Cardiovasc Diabetol. 2017;16:32. https:\/\/doi.org\/10.1186\/s12933-017-0516-8.","journal-title":"Cardiovasc Diabetol"},{"key":"1126_CR102","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12933-017-0658-8","volume":"17","author":"T Sato","year":"2018","unstructured":"Sato T, Aizawa Y, Yuasa S, Kishi S, Fuse K, Fujita S, et al. The effect of dapagliflozin treatment on epicardial adipose tissue volume. Cardiovasc Diabetol. 2018;17:6. https:\/\/doi.org\/10.1186\/s12933-017-0658-8.","journal-title":"Cardiovasc Diabetol"},{"key":"1126_CR103","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16107","author":"Y Bao","year":"2024","unstructured":"Bao Y, Hu Y, Shi M, Zhao Z. SGLT2 inhibitors reduce epicardial adipose tissue more than GLP-1 agonists or exercise interventions in patients with type 2 diabetes mellitus and\/or obesity: a systematic review and network meta-analysis. Diabetes Obes Metab. 2024. https:\/\/doi.org\/10.1111\/dom.16107.","journal-title":"Diabetes Obes Metab"},{"key":"1126_CR104","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12933-023-01738-2","volume":"22","author":"VA Myasoedova","year":"2023","unstructured":"Myasoedova VA, Parisi V, Moschetta D, Valerio V, Conte M, Massaiu I, et al. Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22:23. https:\/\/doi.org\/10.1186\/s12933-023-01738-2.","journal-title":"Cardiovasc Diabetol"},{"key":"1126_CR105","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12933-023-02091-0","volume":"22","author":"F Cinti","year":"2023","unstructured":"Cinti F, Leccisotti L, Sorice GP, Capece U, D\u2019Amario D, Lorusso M, et al. Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes. Cardiovasc Diabetol. 2023;22:349. https:\/\/doi.org\/10.1186\/s12933-023-02091-0.","journal-title":"Cardiovasc Diabetol"},{"key":"1126_CR106","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1253\/circrep.CR-18-0011","volume":"1","author":"M Sano","year":"2018","unstructured":"Sano M. Anti-diabetic agents and heart failure\u2014response to the CARMELINA study. Circ Rep. 2018;1:4\u20137. https:\/\/doi.org\/10.1253\/circrep.CR-18-0011.","journal-title":"Circ Rep"},{"key":"1126_CR107","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1253\/circj.CJ-15-0718","volume":"80","author":"T Mitsuhashi","year":"2016","unstructured":"Mitsuhashi T, Hibi K, Konishi M, Maejima N, Iwahashi N, Tsukahara K, et al. Plasma glucagon-like peptide-1 and tissue characteristics of coronary plaque in non-diabetic acute coronary syndrome patients. Circ J. 2016;80:469\u201376. https:\/\/doi.org\/10.1253\/circj.CJ-15-0718.","journal-title":"Circ J"},{"key":"1126_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.11.001","author":"CM Kramer","year":"2024","unstructured":"Kramer CM, Borlaug BA, Zile MM, Ruff D, DiMaria JM, Menon V, et al. Tirzepatide reduces LV mass and paracardiac adipose tissue in obesity-related heart failure: SUMMIT CMR substudy. J Am Coll Cardiol. 2024. https:\/\/doi.org\/10.1016\/j.jacc.2024.11.001.","journal-title":"J Am Coll Cardiol"},{"key":"1126_CR109","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12933-024-02445-2","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, Yao W, Wang T, Yang Q, Song K, Zhang F, et al. Association of semaglutide treatment with coronary artery inflammation in type 2 diabetes mellitus patients: a retrospective study based on pericoronary adipose tissue attenuation. Cardiovasc Diabetol. 2024;23:348. https:\/\/doi.org\/10.1186\/s12933-024-02445-2.","journal-title":"Cardiovasc Diabetol"},{"key":"1126_CR110","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1707914.","journal-title":"N Engl J Med"},{"key":"1126_CR111","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383:1838\u201347. https:\/\/doi.org\/10.1056\/NEJMoa2021372.","journal-title":"N Engl J Med"},{"key":"1126_CR112","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1253\/circj.CJ-16-0949","volume":"81","author":"K Fujisue","year":"2017","unstructured":"Fujisue K, Sugamura K, Kurokawa H, Matsubara J, Ishii M, Izumiya Y, et al. Colchicine improves survival, left ventricular remodeling, and chronic cardiac function after acute myocardial infarction. Circ J. 2017;81:1174\u201382. https:\/\/doi.org\/10.1253\/circj.CJ-16-0949.","journal-title":"Circ J"},{"key":"1126_CR113","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1253\/circrep.CR-21-0065","volume":"3","author":"AM Abrantes","year":"2021","unstructured":"Abrantes AM, Nogueira-Garcia B, Alves M, Teixeira Passos D, Brito D, Pinto FJ, et al. Low-dose colchicine in coronary artery disease\u2014systematic review and meta-analysis. Circ Rep. 2021;3:457\u201364. https:\/\/doi.org\/10.1253\/circrep.CR-21-0065.","journal-title":"Circ Rep"},{"key":"1126_CR114","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1096\/fj.02-0024com","volume":"16","author":"M L\u00f6hn","year":"2002","unstructured":"L\u00f6hn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J. 2002;16:1057\u201363. https:\/\/doi.org\/10.1096\/fj.02-0024com.","journal-title":"FASEB J"},{"key":"1126_CR115","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/10641969109042063","volume":"13","author":"EE Soltis","year":"1991","unstructured":"Soltis EE, Cassis LA. Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens A. 1991;13:277\u201396. https:\/\/doi.org\/10.3109\/10641969109042063.","journal-title":"Clin Exp Hypertens A"},{"key":"1126_CR116","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1475-2840-11-106","volume":"11","author":"M Dagvasumberel","year":"2012","unstructured":"Dagvasumberel M, Shimabukuro M, Nishiuchi T, Ueno J, Takao S, Fukuda D, et al. Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: a 3-dimensional cardiac computed tomography imaging study in Japanese subjects. Cardiovasc Diabetol. 2012;11:106. https:\/\/doi.org\/10.1186\/1475-2840-11-106.","journal-title":"Cardiovasc Diabetol"},{"key":"1126_CR117","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jjcc.2014.07.004","volume":"65","author":"H Yamada","year":"2015","unstructured":"Yamada H, Sata M. Role of pericardial fat: the good, the bad and the ugly. J Cardiol. 2015;65:2\u20134. https:\/\/doi.org\/10.1016\/j.jjcc.2014.07.004.","journal-title":"J Cardiol"},{"key":"1126_CR118","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.echo.2015.07.006","volume":"28","author":"Y Hirata","year":"2015","unstructured":"Hirata Y, Yamada H, Kusunose K, Iwase T, Nishio S, Hayashi S, et al. Clinical utility of measuring epicardial adipose tissue thickness with echocardiography using a high-frequency linear probe in patients with coronary artery disease. J Am Soc Echocardiogr. 2015;28:1240-1246.e1241. https:\/\/doi.org\/10.1016\/j.echo.2015.07.006.","journal-title":"J Am Soc Echocardiogr"},{"key":"1126_CR119","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1536\/ihj.52.139","volume":"52","author":"Y Hirata","year":"2011","unstructured":"Hirata Y, Kurobe H, Akaike M, Chikugo F, Hori T, Bando Y, et al. Enhanced inflammation in epicardial fat in patients with coronary artery disease. Int Heart J. 2011;52:139\u201342. https:\/\/doi.org\/10.1536\/ihj.52.139.","journal-title":"Int Heart J"},{"key":"1126_CR120","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fphys.2018.00003","volume":"9","author":"K Tanaka","year":"2018","unstructured":"Tanaka K, Sata M. Roles of Perivascular Adipose Tissue in the Pathogenesis of Atherosclerosis. Front Physiol. 2018;9:3. https:\/\/doi.org\/10.3389\/fphys.2018.00003.","journal-title":"Front Physiol"},{"key":"1126_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.720690","volume":"8","author":"A Elsanhoury","year":"2021","unstructured":"Elsanhoury A, Nelki V, Kelle S, Van Linthout S, Tsch\u00f6pe C. Epicardial fat expansion in diabetic and obese patients with heart failure and preserved ejection fraction\u2014a specific HFpEF phenotype. Front Cardiovasc Med. 2021;8: 720690. https:\/\/doi.org\/10.3389\/fcvm.2021.720690.","journal-title":"Front Cardiovasc Med"},{"key":"1126_CR122","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13574","volume":"24","author":"I Akoumianakis","year":"2023","unstructured":"Akoumianakis I, Zagaliotis A, Konstantaraki M, Filippatos TD. GLP-1 analogs and regional adiposity: a systematic review and meta-analysis. Obes Rev. 2023;24: e13574. https:\/\/doi.org\/10.1111\/obr.13574.","journal-title":"Obes Rev"},{"key":"1126_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2022.102562","volume":"16","author":"G Berg","year":"2022","unstructured":"Berg G, Barchuk M, Lobo M, Nogueira JP. Effect of glucagon-like peptide-1 (GLP-1) analogues on epicardial adipose tissue: a meta-analysis. Diabetes Metab Syndr. 2022;16: 102562. https:\/\/doi.org\/10.1016\/j.dsx.2022.102562.","journal-title":"Diabetes Metab Syndr"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-025-01126-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-025-01126-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-025-01126-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T06:58:42Z","timestamp":1749884322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-025-01126-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":123,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1126"],"URL":"https:\/\/doi.org\/10.1007\/s12928-025-01126-5","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that this study was conducted and described in the absence of any commercial or financial relationships that could be considered a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}